An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
This secondary analysis of a randomized clinical trial assesses patient-reported anxiety, depression, and quality of life among patients receiving mindfulness-based stress reduction vs escitalopram for the treatment of anxiety disorders.
Conflict of Interest Disclosures: In the past 3 years, Dr Simon reported receiving grants from the National Institutes of Health (NIH), American Foundation for Suicide Prevention, Patient-Centered Outcomes Research Institute (PCORI), Ananda Scientific and support from Cohen Veterans Network and MindMed; receiving personal fees from Genomind, Cerevel; receiving fees or royalties from Wiley (Deputy Editor Depression and Anxiety), Wolters Kluwer (UpToDate), and APA Publishing; and having spousal stock from G1 Therapeutics and Zentalis outside the submitted work. Dr Bui reported receiving grants from PCORI and a private donor during the conduct of the study. In addition, Dr Bui reported receiving grants from Réseau d’Intérêt Normandie and the University Hospital Center of Caen, receiving royalties from Springer and Wolters Kluwer Health, and receiving consulting fees from Cerevel Therapeutics outside the submitted work. Dr Hoge reported receiving grants from PCORI during the conduct of the study. No other disclosures were reported.
References
Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol. 2010;78(2):169-183. doi:10.1037/a0018555
-
DOI
-
PMC
-
PubMed
Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM. Mindfulness-based stress reduction vs escitalopram for the treatment of adults with anxiety disorders: a randomized clinical trial. JAMA Psychiatry. 2023;80(1):13-21. doi:10.1001/jamapsychiatry.2022.3679
-
DOI
-
PMC
-
PubMed
Hoge EA, Bui E, Mete M, et al. . Treatment for Anxiety: Mindfulness Meditation Versus Escitalopram (TAME): design of a randomized, controlled non-inferiority trial. Contemp Clin Trials. 2020;91:105965. doi:10.1016/j.cct.2020.105965
-
DOI
-
PubMed
Ebrahiminejad S, Poursharifi H, Bakhshiour Roodsari A, Zeinodini Z, Noorbakhsh S. The effectiveness of mindfulness-based cognitive therapy on Iranian female adolescents suffering from social anxiety. Iran Red Crescent Med J. 2016;18(11):e25116. doi:10.5812/ircmj.25116
-
DOI
-
PMC
-
PubMed